645 related articles for article (PubMed ID: 30414516)
1. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics.
Tiberti N; Sanchez JC
Data Brief; 2015 Sep; 4():400-5. PubMed ID: 26306311
[TBL] [Abstract][Full Text] [Related]
3. Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.
Tiberti N; Hainard A; Lejon V; Robin X; Ngoyi DM; Turck N; Matovu E; Enyaru J; Ndung'u JM; Scherl A; Dayon L; Sanchez JC
Mol Cell Proteomics; 2010 Dec; 9(12):2783-95. PubMed ID: 20724469
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid-Derived Microvesicles From Sleeping Sickness Patients Alter Protein Expression in Human Astrocytes.
Dozio V; Lejon V; Mumba Ngoyi D; Büscher P; Sanchez JC; Tiberti N
Front Cell Infect Microbiol; 2019; 9():391. PubMed ID: 31824868
[TBL] [Abstract][Full Text] [Related]
5. [Human African trypanosomiasis].
Dumas M; Bouteille B
C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of human African trypanosomiasis.
Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
Kennedy PGE; Rodgers J
Front Immunol; 2019; 10():39. PubMed ID: 30740102
[TBL] [Abstract][Full Text] [Related]
8. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086
[TBL] [Abstract][Full Text] [Related]
9. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
10. Human African trypanosomiasis in non-endemic countries.
Sudarshi D; Brown M
Clin Med (Lond); 2015 Feb; 15(1):70-3. PubMed ID: 25650203
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
12. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
[TBL] [Abstract][Full Text] [Related]
13. Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.
Kande Betu Ku Mesu V; Mutombo Kalonji W; Bardonneau C; Valverde Mordt O; Ngolo Tete D; Blesson S; Simon F; Delhomme S; Bernhard S; Mahenzi Mbembo H; Mpia Moke C; Lumeya Vuvu S; Mudji E'kitiak J; Akwaso Masa F; Mukendi Ilunga M; Mpoyi Muamba Nzambi D; Mayala Malu T; Kapongo Tshilumbwa S; Botalema Bolengi F; Nkieri Matsho M; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet Glob Health; 2021 Jul; 9(7):e999-e1008. PubMed ID: 34143998
[TBL] [Abstract][Full Text] [Related]
14. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.
MacLean L; Reiber H; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191
[TBL] [Abstract][Full Text] [Related]
15. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
16. The separation of trypanosomes from blood by anion exchange chromatography: From Sheila Lanham's discovery 50 years ago to a gold standard for sleeping sickness diagnosis.
Lejon V; Büscher P; Nzoumbou-Boko R; Bossard G; Jamonneau V; Bucheton B; Truc P; Lemesre JL; Solano P; Vincendeau P
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007051. PubMed ID: 30817751
[TBL] [Abstract][Full Text] [Related]
17. Human African trypanosomiasis in endemic populations and travellers.
Blum JA; Neumayr AL; Hatz CF
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):905-13. PubMed ID: 21901632
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
[TBL] [Abstract][Full Text] [Related]
19. Human African trypanosomiasis.
Lejon V; Bentivoglio M; Franco JR
Handb Clin Neurol; 2013; 114():169-81. PubMed ID: 23829907
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]